Makonen Belema

2.0k total citations · 1 hit paper
18 papers, 1.2k citations indexed

About

Makonen Belema is a scholar working on Hepatology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Makonen Belema has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hepatology, 7 papers in Organic Chemistry and 7 papers in Molecular Biology. Recurrent topics in Makonen Belema's work include Hepatitis C virus research (10 papers), HIV/AIDS drug development and treatment (6 papers) and Hepatitis B Virus Studies (4 papers). Makonen Belema is often cited by papers focused on Hepatitis C virus research (10 papers), HIV/AIDS drug development and treatment (6 papers) and Hepatitis B Virus Studies (4 papers). Makonen Belema collaborates with scholars based in United States, Russia and Germany. Makonen Belema's co-authors include Nicholas A. Meanwell, Frederick E. Ziegler, Van N. Nguyen, Donald R. O’Boyle, Julie A. Lemm, Robert A. Fridell, Jin-Hua Sun, Lawrence B. Snyder, Chunfu Wang and David R. Langley and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Makonen Belema

18 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

2010 689 citations Min Gao, Richard E. Nettles et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Makonen Belema United States	13	749	558	322	292	280	18	1.2k
Michael H. Serrano‐Wu United States	18	795 1.1×	633 1.1×	350 1.1×	307 1.1×	342 1.2×	31	1.4k
Van N. Nguyen United States	12	639 0.9×	498 0.9×	260 0.8×	303 1.0×	219 0.8×	14	1.1k
Shalini Bansal United States	14	710 0.9×	609 1.1×	654 2.0×	224 0.8×	440 1.6×	29	1.4k
Pierre Raboisson Belgium	24	636 0.8×	534 1.0×	497 1.5×	555 1.9×	634 2.3×	60	1.8k
Vincent Lévêque United States	28	803 1.1×	643 1.2×	659 2.0×	219 0.8×	549 2.0×	41	1.7k
Holly M. Micolochick Steuer United States	16	957 1.3×	811 1.5×	845 2.6×	202 0.7×	489 1.7×	27	1.6k
Meg Keilman United States	9	609 0.8×	482 0.9×	522 1.6×	181 0.6×	319 1.1×	12	1.1k
Christine Espiritu United States	17	1.1k 1.5×	1.0k 1.8×	810 2.5×	163 0.6×	502 1.8×	34	1.8k
Bruce S. Ross United States	17	551 0.7×	452 0.8×	644 2.0×	351 1.2×	762 2.7×	42	1.6k
Murray D. Bailey Canada	15	465 0.6×	230 0.4×	273 0.8×	609 2.1×	321 1.1×	25	1.2k

Countries citing papers authored by Makonen Belema

Since Specialization

Citations

This map shows the geographic impact of Makonen Belema's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makonen Belema with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makonen Belema more than expected).

Fields of papers citing papers by Makonen Belema

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Makonen Belema. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makonen Belema. The network helps show where Makonen Belema may publish in the future.

Co-authorship network of co-authors of Makonen Belema

This figure shows the co-authorship network connecting the top 25 collaborators of Makonen Belema. A scholar is included among the top collaborators of Makonen Belema based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makonen Belema. Makonen Belema is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Sridharan, R., Makonen Belema, Nicholas A. Meanwell, et al.. (2019). Facile Access to 1,4-Disubstituted Pyrrolo[1,2-a]pyrazines from α-Aminoacetonitriles. Synthesis. 52(3). 441–449. 3 indexed citations

Belema, Makonen, Omar D. Lopez, John A. Bender, et al.. (2014). Discovery and Development of Hepatitis C Virus NS5A Replication Complex Inhibitors. Journal of Medicinal Chemistry. 57(5). 1643–1672. 50 indexed citations

Belema, Makonen, Van N. Nguyen, J. Romine, et al.. (2014). Hepatitis C Virus NS5A Replication Complex Inhibitors. Part 6: Discovery of a Novel and Highly Potent Biarylimidazole Chemotype with Inhibitory Activity Toward Genotypes 1a and 1b Replicons. Journal of Medicinal Chemistry. 57(5). 1995–2012. 20 indexed citations

Belema, Makonen & Nicholas A. Meanwell. (2014). Discovery of Daclatasvir, a Pan-Genotypic Hepatitis C Virus NS5A Replication Complex Inhibitor with Potent Clinical Effect. Journal of Medicinal Chemistry. 57(12). 5057–5071. 71 indexed citations

O’Boyle, Donald R., Jin-Hua Sun, Peter T. Nower, et al.. (2013). Characterizations of HCV NS5A replication complex inhibitors. Virology. 444(1-2). 343–354. 35 indexed citations

Gao, Min, Donald R. O’Boyle, Julie A. Lemm, et al.. (2013). 1424 SYNERGISTIC INTERACTIONS OF HCV NS5A REPLICATION COMPLEX INHIBITORS SENSITIZE RESISTANT VARIANTS AND ENHANCE THE EFFICACY OF DACLATASVIR (DCV, BMS-790052) IN VITRO AND IN VIVO. Journal of Hepatology. 58. S573–S574. 3 indexed citations

Wang, Gan, Clint A. James, Nicholas A. Meanwell, Lawrence G. Hamann, & Makonen Belema. (2013). A scalable synthesis of (1R,3S,5R)-2-(tert-butoxycarbonyl)-2-azabicyclo[3.1.0]hexane-3-carboxylic acid. Tetrahedron Letters. 54(49). 6722–6724. 11 indexed citations

Belema, Makonen, Van N. Nguyen, Denis R. St. Laurent, et al.. (2013). HCV NS5A replication complex inhibitors. Part 5: Discovery of potent and pan-genotypic glycinamide cap derivatives. Bioorganic & Medicinal Chemistry Letters. 23(15). 4428–4435. 11 indexed citations

Lopez, Omar D., Van N. Nguyen, Denis R. St. Laurent, et al.. (2012). HCV NS5A replication complex inhibitors. Part 3 : discovery of potent analogs with distinct core topologies. Bioorganic & Medicinal Chemistry Letters. 23(3). 779–784. 23 indexed citations

10.

Qiu, Dike, Julie A. Lemm, Donald R. O’Boyle, et al.. (2011). The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization. Journal of General Virology. 92(11). 2502–2511. 44 indexed citations

11.

Gao, Min, Richard E. Nettles, Makonen Belema, et al.. (2010). Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect. Nature. 465(7294). 96–100. 689 indexed citations breakdown →

12.

Belema, Makonen, Amy Bunker, Van N. Nguyen, et al.. (2007). Synthesis and structure–activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-β inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(15). 4284–4289. 26 indexed citations

13.

Beaulieu, Françis, Carl Ouellet, Edward H. Ruediger, et al.. (2006). Synthesis and biological evaluation of 4-amino derivatives of benzimidazoquinoxaline, benzimidazoquinoline, and benzopyrazoloquinazoline as potent IKK inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(5). 1233–1237. 45 indexed citations

14.

Meanwell, Nicholas A., Makonen Belema, David J. Carini, et al.. (2005). Developments in Antiviral Drug Design, Discovery and Development in 2004. PubMed. 5(4). 307–400. 4 indexed citations

15.

Belema, Makonen, Van N. Nguyen, & F. Christopher Zusi. (2004). Synthesis of 1,1-diarylethylenes from an α-stannyl β-silylstyrene. Tetrahedron Letters. 45(8). 1693–1697. 19 indexed citations

16.

Klaholz, Bruno P., et al.. (2000). Enantiomer discrimination illustrated by high-resolution crystal structures of the human nuclear receptor hRARγ. Proceedings of the National Academy of Sciences. 97(12). 6322–6327. 62 indexed citations

17.

Ziegler, Frederick E. & Makonen Belema. (1997). Chiral Aziridinyl Radicals: An Application to the Synthesis of the Core Nucleus of FR-900482. The Journal of Organic Chemistry. 62(4). 1083–1094. 82 indexed citations

18.

Ziegler, Frederick E. & Makonen Belema. (1994). Cyclization of Chiral Carbon-Centered Aziridinyl Radicals: A New Route to Azirino[2',3':3,4]pyrrolo[1,2-a]indoles. The Journal of Organic Chemistry. 59(26). 7962–7967. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact